¹⁸F-FDG PET/CT of Oligometastatic Disease in Locally Advanced Breast Cancer: PETABC Trial Post Hoc Analysis

At initial staging of locally advanced invasive ductal carcinoma, fluorine 18 fluorodeoxyglucose PET/CT helped to identify oligometastatic disease in 10% of patients and supraclavicular and/or internal mammary lymph node metastases in approximately one-third of patients.